Navin Fluorine International earnings calls.

Navin Fluorine delivered an exceptional Q1 FY27 with consolidated revenue of Rs 1,045 croreCurrent reported value: Rs 1,045 crore. No comparable prior figure is available in the source record. (+44Current 44 crore vs previous available quarter 46 crore.% YoY), EBITDA of Rs 357 croreCurrent 357 crore vs previous available quarter 246 crore. (+73% YoY), and PAT of Rs 243 croreCurrent reported value: Rs 243 crore. No comparable prior figure is available in the source record. (+108Current reported value: 108. No comparable prior figure is available in the source record.% YoY). EBITDA margin expanded 566bps to 34.2Current 34.2 crore vs previous available quarter 32.5 crore.%. All three verticals performed strongly: HPP (Rs 540 crore, +33%) benefited from volume growth and improved realizations in a constructive HFC pricing environment; Specialty Chemicals (Rs 325 crore, +48%) sustained momentum with good order visibility across existing and new molecules; CDMO (Rs 180 crore, +82%) deepened its European partnership with an additional molecule MSA. Management announced strategic capex including Rs 90 crore for advanced materials adoption capacity (Q2 FY28) and Rs 125 crore for CDMO Phase 2 CGMP (Q4 FY27). Key initiatives include the DRDO partnership for indigenous specialty materials and the Kimos liquid cooling project (Q2 FY27 completion). Looking ahead, medium-term margin guidance of 32-33% ±1% reflects confidence in operating leverage from upcoming capacities. Risk factors include specialty chemical pricing pressure in LatAm and raw material inflation impacting gross margins, though management indicated intent to pass through where pricing power exists.